PacBio to Present at Cowen's 43rd Annual Health Care Conference
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
PacBio (NASDAQ: PACB), a leader in high-quality sequencing solutions, will participate in Cowen's 43rd Annual Health Care Conference on March 7, 2023, at 12:50 PM ET. The event will feature a fireside chat with company management, available via a live and archived webcast on the investor page at pacb.com. PacBio is focused on addressing complex genetic challenges through advanced sequencing technologies, including HiFi long read and SBB short read sequencing. The company's solutions are applicable across various research domains, such as human germline sequencing, oncology, and infectious disease.
Details
News Market Reaction – PACB
The recorded move for PACB in the trading session of this news was +2.74%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MENLO PARK, Calif., Feb. 27, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that it will be participating in Cowen's 43rd Annual Health Care Conference in Boston, Massachusetts.
PacBio management is scheduled to participate in a fireside chat on Tuesday, March 7th at 12:50 PM ET. Interested parties may access a live and archived webcast of the event at the company's investors page at investor.pacificbiosciences.com.
About PacBio
Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technology under development stem from two highly differentiated core technologies focused on accuracy, quality and completeness which include our existing HiFi long read sequencing and our emerging SBB™ short read sequencing technologies. Our products address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.
Contacts
Investors:
Todd Friedman
650.521.8450
ir@pacb.com
Media:
Lizelda Lopez
pr@pacb.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/pacbio-to-present-at-cowens-43rd-annual-health-care-conference-301756079.html
SOURCE Pacific Biosciences of California, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.